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American agriculture is on the threshold of a major technological revo-
lution, one that will be propelled by the combined forces of the elec-
tronic age and a new wave of innovations based upon biotechnology. 
This revolution portends sweeping changes, both in terms of enhanced 
farm productivity/efficiency and in the potential for a major restruc-
turing of the agricultural industry.
This paper examines two soon to be released products of this bio-
technological revolution, bovine (BST) and porcine (PST) somatotro-
pin. Both BST and PST are naturally-occurring hormones, produced 
in the pituitary glands of animals, that accelerate metabolism and 
growth rates. Recent biotech advances have permitted scientists to 
“manufacture” these substances in mass quantities, thereby making 
their use economically attractive in the swine and dairy industries. 
Both products are currently being tested by the Food and Drug Admin-
istration (FDA) and should be on the market within the next two 
years. This paper, using an ex-ante model of adoption, examines the 
receptivity of Iowa pork producers to PST.
PREVIOUS STUDIES ON SPEED OF ADOPTION AND IMPACTS
Virtually all of the research on farmers’ propensity to adopt growth 
hormones has focused on BST; adoption studies of PST are virtually 
nonexistent. Two early studies of BST had a dramatic impact on the 
public imagery of the virtues and likely impacts of this product. In
1986, a much publicized Congressional Office of Technology Assess-
ment (OTA) report concluded that biotechnological innovations 
would have revolutionary impacts on U.S. agriculture, bringing a dra-
matic decline in the number of farms and a startling increase in the 
concentration of agricultural production. It was also concluded that 
adoption of the new technologies would initially be concentrated on 
large, highly capitalized operations, thus further solidifying the eco-
nomic advantages enjoyed by those units and accentuating the trend 
toward a dual farm structure.
The other study, conducted by scientists at Cornell University in-
troduced the possibility of significant increases in milk production (by 
as much as 40 percent) from BST use. Through ex-ante assessment, a 
rapid adoption of BST was projected, with an estimate that two-thirds 
of New York dairy operators would adopt the product in the first year 
of its availability. It was concluded that the introduction of BST would 
accelerate the already rapid changes taking place in the dairy industry, 
and bring the demise of up to 1000 dairy herds annually in New York 
State alone.
More recent studies have shown relatively smaller productivity in-
creases (10-15 percent) from BST, and slower rates of diffusion of this 
product among farm operators. Fallert, for example, argued that the 
effects of BST on the dairy industry will be less dramatic than earlier 
thought, and concluded that BST will merely reinforce a thirty year 
trend toward increased efficiency and diminished farm numbers. Re-
cent studies also suggest that there is substantially more farmer resis-
tance to BST than was initially predicted. Upwards of a third of the 
dairy operators in California and Wisconsin, for example, are not plan-
ning to adopt this product.
Societal impacts anticipated from the diffusion of growth hor-
mones have ranged widely and have included an acceleration in the 
displacement of farm families, lessened viability and survival of rural 
communities, and increased degradation of the natural environment. 
The public response to growth hormones, especially BST, has been pro-
foundly shaped by these perceived negative outcomes and has led in 
some states to legislative initiatives to place a moratorium on their use 
in some states.
That most of the public controversy has thus far centered on BST 
and comparatively little on PST is a result of the fact that:
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1 socioeconomic impact studies have focused almost exclusively on 
BST and have projected major increases in milk production and a 
commensurate displacement of dairy farmers, 2 dairying normally has 
a high level of centrality in the total farming system, whereas pork is 
typically part of a more diversified operation, and 3 whereas BST 
brings substantial production increases in a food product for which 
there is already a chronic surplus, PST acts as a repartitioning agent 
and facilitates the production of a leaner, improved meat product.
THE IOWA PST STUDY
To assess the farmers’ receptivity to PST, an ex-ante adoption study of 
porcine somatotropin was recently conducted. Two groups, a repre-
sentative sample of Iowa pork producers (N=250) and a purposive na-
tional sample of large-scale pork producers (N = 19) participated in the 
study. The Iowa sample averaged 1,100 slaughter hogs marketed an-
nually, compared to 181,000 slaughter hogs for the national sample.
Awareness of PST among the Iowa producers is quite low, especially 
when compared to awareness levels for BST (which recently have ave-
raged about 80 percent of all dairy operators). Only 17 percent of the 
Iowa sample perceived themselves as well or very well informed about 
PST, compared to 81 percent of the large-scale producers.
SPEED OF ADOPTION
Ex-ante adoption studies permit the projection of social and economic 
impacts of innovations that are not yet commercially available. These 
studies require the preparation of scenarios that define parameters of 
the innovation. Generally, the scenarios are developed with current 
“state-of-the-art” knowledge and identify both the relative advanta-
ges and potential disadvantages of the product. Benefits of PST inclu-
ded in this study’s scenario were improved feed efficiency, increased 
daily weight gain, improved carcass composition, and an attractive 
financial return on the operator's investment. Costs of PST included 
increased labor requirements (in the form of bi-weekly injections), 
increased protein requirements, more intensive management systems, 
the possibility of lower market prices, and the potential for adverse 
consumer reaction to the use of hormones.
A benefit/cost scenario was presented to the respondents, and, after 
securing their general reaction to the product, they were asked how 
quickly they would adopt it. The Iowa respondents were cautious— 
only two percent said that they would likely adopt PST immediately
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for use on their farms, and an additional 22 percent anticipated they 
would likely adopt the product within a year. Twenty-five percent 
said they would adopt PST in one to two years and seven percent 
would take more than two years. Thirty-five percent of the Iowa sam-
ple said they would not adopt PST.
In comparison to the Iowa sample, the national sample of large scale 
producers were enthusiastic about PST, with 32 percent planning to 
adopt it immediately, and another 37 percent within the first year. Ten 
percent said they would take more than a year to adopt, and five per-
cent (one operator) did not expect to ever adopt it.
Revised versions of the scenario (in which financial return and 
number of injections required were altered) were presented to the res-
pondents to gauge the significance of these changes for their speed of 
adoption. As expected, increased financial returns brought accelerated 
adoption—a $5:1 rate of return, instead of the $3:1 rate specified in 
the scenario, jumped the first year rate of adoption from 24 percent to 
50 percent among Iowa producers and from 69 percent to 90 percent 
among large-scale producers. A reduced return of $2:1 led to 17 percent 
of the Iowa sample and 47 percent of the national sample adopting in 
the first year.
Alterations in the delivery system of PST also had a pronounced im-
pact on the anticipated speed of farmers’ adoptions. Dropping the re-
quired number of injections from four (as specified in the scenario) to 
two increased the number of first year adoptions from 24 percent to 
50 percent among Iowa producers and from 69 percent to 79 percent 
among large-scale producers. Conversely, doubling the number of re-
quired injections from four to eight prompted a significant decrease in 
first year adoptions, which fell to five percent of the Iowa sample and 
42 percent of the national sample.
CORRELATES OF ADOPTION
Ex-ante studies of the adoption of BST have generally shown early 
adopters to be better educated, more efficient, and milking larger 
herds than persons adopting later or nonadopters. These findings have 
prompted the conclusion that large, more capital intensive farming 
operations will reap disproportionate benefits (windfall profits) as a 
result of their increased outputs, lower per unit production costs, and 
higher profits in the marketplace from early adoptions. Because of in-
creased productivity and lower market prices, persons adopting later
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are typically denied these financial benefits. For the Iowa sample, posi-
tive relationships were found between speed of adoption and size of 
the hog operations, knowledge of PST, innovativeness, risk orienta-
tion, and perceived consumer acceptance. Age was not important for 
speed of adoption and education and acres farmed were of only minor 
importance.
WHO BENEFITS?
An industry representative has recently concluded that the introduc-
tion of PST will be a “win-win-win” situation, with the interests of 
hog producers, packers, and consumers all being served. When asked 
for their perceptions of the likely beneficiaries of PST, the Iowa sample 
was divided on their assessments. Whereas 80 percent perceived that 
large operators would benefit from PST, only 42 percent and 18 per-
cent, respectively, anticipated that benefits would also accrue to me-
dium and small-scale producers.
Large-scale producers were generally more optimistic about the 
equity of PST impacts, with 47 percent anticipating that small produ-
cers would benefit, and 63 percent and 79 percent, respectively, feeling 
that medium- and large- scale producers would benefit. Sixty-two 
percent of the Iowa sample and 84 percent of the national sample felt 
that meatpackers would benefit from PST, while 33 percent of the 
Iowa sample and 95 percent of the national sample saw consumers as 
beneficiaries. A sizeable proportion of the Iowa sample (40 percent) 
were uncertain whether PST would benefit or harm consumers.
CONCLUSION
Ex-ante studies of adoption have been heralded as permitting the pre-
diction of future conditions and as informing public policy about po-
tential impacts of innovations prior to their release. But it is clear that 
current agricultural policy cannot prevent potentially adverse out-
comes, such as labor displacement from the introduction of new tech-
nologies, even if these outcomes are accurately predicted. The question 
is thus “whether, the ex-ante study*!” Increased public and scientific 
debate on this question seems warranted. A possible starting point for 
this debate has been suggested by Dupuis and Geisler, who note that 
ex-ante studies need to pay greater attention to the institutional 
structures that undergird agriculture. They conclude that the claimed 
scale neutrality of new technologies, such as BST and PST, are not in-
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evitable, but only a possibility that depends upon existing institu-
tional contexts. Ex-ante studies can play an important role by identi-
fying institutional barriers to the equitable transfer of new technolo-
gies and by providing needed information for better anticipation and 
structural consequences of their adoption.
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